viral
hemorrhag
fever
vhf
constitut
group
clinic
similar
diseas
character
mild
sever
febril
acut
syndrom
vascular
damag
plasma
leakag
bleed
clinic
preval
human
hemorrhag
fever
virus
belong
famili
arenavirida
filovirida
hantavirida
flavivirida
share
structur
replic
characterist
figur
well
immun
issu
host
inde
famili
arenavirida
hantavirida
belong
order
bunyaviral
howev
pathogenesi
role
immun
system
develop
mild
sever
diseas
protect
pathogen
function
compon
immun
system
still
clear
particularli
contribut
tcell
mediat
immun
diseas
protect
pathogenesi
yet
character
especi
import
associ
magnitud
tcell
respons
diseas
surviv
diseas
exacerb
thu
appar
tcell
play
contextdepend
role
vhf
necessari
defin
order
improv
patient
clinic
outcom
develop
vaccin
immunotherapeut
strategi
discuss
role
tcell
control
vhf
diseas
pathogenesi
potenti
contribut
vaccin
develop
tcell
respons
featur
repres
virus
famili
lassa
viru
lasv
arenaviru
ebola
viru
ebov
filoviru
hantaan
viru
htnv
hantaviru
dengu
viru
denv
flaviviru
address
sinc
studi
vaccin
yellow
fever
viru
yfv
larg
contribut
understand
dynam
human
tcell
differenti
viral
infect
larg
bodi
evid
support
role
tcell
effect
vaccin
also
discuss
tcell
respons
yfv
vaccin
vhf
transmit
persontoperson
direct
contact
contamin
bodi
fluid
tissu
vhf
also
zoonot
natur
spread
differ
mechan
depend
viru
transmit
consumpt
raw
meat
fluid
infect
anim
direct
contact
rodent
bat
inhal
contact
materi
contamin
rodent
excreta
other
vectorborn
diseas
transmit
bite
infect
mosquito
tick
diseas
clinic
dynam
rang
asymptomat
sever
diseas
death
rapidli
progress
sever
stage
hour
day
absenc
highli
special
laboratori
train
personnel
limit
capac
earli
diagnosi
vhf
particularli
endem
area
similarli
lack
approv
specif
therapi
contribut
diseas
burden
unfavor
clinic
outcom
epidemiolog
vhf
highli
variabl
consid
geograph
distribut
natur
reservoir
vector
around
world
differ
syndrom
caus
virus
lassa
fever
endem
west
africa
clinic
infect
estim
year
mortal
howev
nosocomi
outbreak
occur
fatal
rate
addit
case
fatal
rate
reach
among
patient
assist
health
care
facil
repres
sever
lasv
infect
ebov
caus
sporad
outbreak
central
west
africa
report
fatal
rate
major
outbreak
recent
outbreak
occur
democrat
republ
congo
decemb
case
confirm
fatal
rate
hantavirus
old
world
htnv
puumala
viru
caus
hemorrhag
fever
renal
syndrom
hfr
mainli
china
korea
northeastern
europ
hantavirus
new
world
and
choclo
viru
caus
hantaviru
pulmonari
syndrom
hp
case
report
unit
state
canada
brazil
chile
argentina
panama
roughli
case
per
year
hp
unit
state
case
fatal
sever
mortal
associ
hantaviru
syndrom
vari
accord
caus
viru
death
hfr
usual
due
renal
insuffici
shock
sever
hemorrhag
yellow
fever
endem
tropic
area
subsaharan
africa
central
south
america
despit
effect
vaccin
coverag
low
particularli
area
africa
introduct
unvaccin
individu
area
harbor
mosquito
genu
aed
lead
dissemin
viru
major
outbreak
inde
endem
area
africa
approxim
sever
hepat
may
caus
yfv
infect
year
case
yellow
fever
estim
includ
death
nearli
case
confirm
africa
moreov
outbreak
occur
nigeria
confirm
case
fatal
rate
fewer
case
estim
occur
america
due
higher
vaccin
coverag
howev
yellow
fever
outbreak
occur
sever
countri
brazil
yellow
fever
case
death
confirm
individu
travel
endem
area
also
highli
affect
yellow
fever
dengu
fever
major
public
health
concern
least
billion
peopl
risk
infect
vector
mosquito
genu
aed
distribut
tropic
subtrop
urban
rural
area
four
denv
serotyp
caus
dengu
fever
clinic
classifi
dengu
sever
dengu
dengu
turn
subdivid
dengu
without
warn
sign
warn
sign
least
million
denv
infect
estim
per
year
although
less
clinic
symptomat
least
sever
dengu
case
relat
death
estim
occur
annual
thu
vhf
import
health
concern
worldwid
improv
prevent
diagnosi
treatment
option
requir
limit
impact
diseas
larg
gap
understand
role
tcell
subpopul
pathogenesi
vhf
among
regulatori
tcell
import
subset
essenti
control
exacerb
immun
respons
limit
chronic
inflamm
strikingli
frequenc
circul
regulatori
tcell
remain
unchang
ebov
hantavirus
sever
denv
infect
may
account
massiv
tcell
activ
chronic
inflamm
diseas
sever
observ
infect
unchang
decreas
proport
regulatori
tcell
observ
immun
vaccin
subset
activ
vaccin
frequenc
posit
correl
magnitud
total
activ
tcell
consist
induct
regulatori
respons
set
high
tcell
activ
tcell
regulatori
mechan
express
inhibitori
receptor
cytotox
tlymphocyt
antigen
program
death
protein
well
high
level
regulatori
cytokin
would
exert
regulatori
role
diseas
discuss
tcell
subset
tcell
also
evalu
vhf
propos
antivir
role
bridg
innat
adapt
immun
particularli
product
final
specif
effector
tcell
profil
cell
relat
regulatori
gene
increas
challeng
hemorrhag
fever
virus
implic
protect
function
nonetheless
studi
requir
defin
role
nonconvent
tcell
subset
vhf
larg
bodi
evid
support
critic
role
tcell
control
lasv
infect
especi
poor
humor
respons
elicit
infect
consid
howev
lasv
induc
profound
immun
defect
cellular
organ
level
earli
report
show
nonhuman
primat
fatal
lasv
infect
exhibit
poor
tcell
respons
mitogen
viral
replic
damag
secondari
lymphoid
organ
pronounc
lymphopenia
also
observ
fatal
lasv
infect
moreov
earli
low
delay
activ
tcell
low
cytokin
product
high
viral
load
associ
fatal
lasv
diseas
consist
inadequ
activ
signal
provid
antigenpres
cell
certainli
lasv
infect
human
monocytederiv
dendrit
cell
impair
cytokin
secret
express
costimulatori
molecul
tcellstimul
capac
condit
tcell
unabl
differenti
effector
memori
cell
control
viral
replic
hla
class
ii
key
tcell
transcript
factor
gene
also
downregul
cell
virem
lymphocyt
choriomening
viru
lcmv
weinfect
macaqu
model
pathogen
lasv
infect
human
dendrit
cell
defect
appear
diseasespecif
infect
human
dendrit
cell
closelyrel
nonpathogen
mopeia
viru
mopv
elicit
earli
strong
tcell
respons
addit
crosstalk
dendrit
cell
tcell
may
requir
effici
cellular
immun
respons
thu
impair
earli
tcell
activ
may
account
uncheck
viral
replic
sever
lasv
diseas
contrast
nonpathogen
arenavirus
alter
tcell
observ
lcmvwe
macaqu
model
includ
decreas
tcell
possibl
cytokinemedi
apoptosi
final
differ
found
immun
respons
old
new
world
arenavirus
review
mention
lasv
infect
character
immun
suppress
wherea
new
world
arenaviru
junin
infect
proce
massiv
cytokin
secret
addit
appar
tcell
may
less
critic
antibodi
respons
protect
junin
viru
infect
despit
aforement
impair
tcell
respons
lasv
infect
evid
protect
role
diseas
includ
presenc
strong
partial
crossreact
tcell
respons
individu
live
area
lasv
endem
may
exert
protect
viral
reexposur
ii
associ
magnitud
function
lasvspecif
tcell
viral
clearanc
nonfat
human
infect
iii
surviv
lasvinfect
macaqu
associ
activ
prolifer
cytokin
product
tcell
respons
lasv
antigen
iv
tcellmedi
protect
lasv
vaccin
candid
nonhuman
primat
rodent
v
tcellmedi
protect
lethal
arenaviru
challeng
nonhuman
primat
previous
expos
pathogen
arenavirus
lasv
infect
macaqu
increas
proport
activ
prolifer
tcell
observ
particularli
nonfat
diseas
decreas
proport
tcell
also
observ
lasvinfect
macaqu
consist
differenti
effector
cell
similarli
surviv
human
be
lasv
infect
correspond
larg
increas
proport
activ
hladr
tcell
phenotyp
consist
effector
memori
profil
lasvspecif
tcell
also
exhibit
effector
memori
phenotyp
interestingli
peak
lasvspecif
tcell
well
polyfunct
cytokin
tcell
respons
observ
day
symptom
onset
coincid
viral
clearanc
remark
major
histocompat
complex
mhc
class
knockout
mice
exhibit
persist
lasv
replic
consist
import
role
tcell
lasv
control
tcell
continu
encount
lasv
epitop
stimul
monocytemacrophag
secret
proinflammatori
cytokin
therebi
contribut
prolong
pathogenesi
certainli
convalesc
phase
human
lasv
infect
antigenspecif
tcell
exhibit
high
product
associ
develop
lymphaden
epididym
chill
absenc
detect
viremia
find
support
hypothesi
lasv
antigen
persist
consequ
activ
tcell
possibl
immunemedi
patholog
tcell
epitop
describ
lasv
protein
particularli
nucleoprotein
ex
vivo
stimul
lasv
nucleoprotein
peptid
elicit
strong
prolif
cytokin
respons
human
tcell
individu
live
lasv
endem
area
lasv
nucleoprotein
peptid
predict
comput
analysi
also
induc
tcell
respons
transgen
mice
addit
tcell
acut
lasvinfect
patient
found
specif
glycoprotein
tetram
tcell
transgen
mice
recogn
peptid
lasv
glycoprotein
precursor
exert
protect
lasv
challeng
cbaj
mice
immun
mopvlasv
reassort
viru
also
exhibit
respons
lasv
glycoprotein
similarli
human
tcell
recogn
highli
conserv
amino
acid
peptid
locat
ntermin
part
lasv
glycoprotein
strong
prolifer
product
ex
vivo
stimul
vesicular
stomat
viru
vector
express
lasv
glycoprotein
modifi
vaccinia
ankaralasv
produc
viruslik
particl
also
elicit
tcell
product
protein
protect
nonhuman
primat
mice
lasv
challeng
thu
vaccin
candid
abl
induc
tcell
specif
lasv
nucleoprotein
glycoprotein
effici
longlast
protect
comparison
ebov
survivor
fatal
reveal
diseas
surviv
associ
earli
detect
ebovspecif
tcell
sustain
tcell
cytokin
express
wherea
fatal
ebov
case
associ
high
express
inhibitori
receptor
well
increas
lymphocyt
apoptosi
certainli
ebov
diseas
character
apoptosi
tcell
attribut
activationinduc
cell
death
mechan
direct
lysi
via
ebov
gp
tcell
dysfunct
ebov
also
affect
tcell
activ
human
dendrit
cell
mechan
prevent
develop
effici
adapt
tcell
respons
ebovinfect
individu
importantli
murin
studi
tcell
appear
play
major
role
control
ebov
infect
evid
support
idea
includ
adopt
transfer
tcell
mice
infect
mouseadapt
ebov
confer
protect
ebovchalleng
mice
ii
tcelldefici
tcell
bcelldefici
mice
die
acut
infect
mouseadapt
ebov
iii
tcell
requir
protect
ebovlik
particl
mous
immun
accord
find
cytokin
respons
ebov
peptid
stimul
predominantli
found
human
tcell
human
be
surviv
diseas
ebov
infect
induc
massiv
activ
termin
differenti
tcell
increas
frequenc
activ
hladr
cell
prolifer
cell
effector
memori
termin
effector
memori
cell
even
day
ill
viral
compon
found
blood
convent
method
hand
excess
tcell
activ
associ
fatal
ebov
infect
human
consist
expans
effector
memori
cell
tcell
ebovinfect
patient
also
equip
high
content
granzym
b
low
express
addit
cell
express
receptor
suggest
could
home
inflam
tissu
appar
longlast
activ
tcell
maintain
persist
lowlevel
antigen
sanctuari
site
particularli
moder
sever
diseas
found
eye
brain
test
ebovinfect
rhesu
monkey
urin
sweat
sever
ill
patient
inde
patient
mild
diseas
rapid
viremia
clearanc
faster
contract
activ
tcell
respons
persist
antigen
load
tcell
chronic
activ
could
contribut
socal
postebov
diseas
syndrom
character
musculoskelet
pain
headach
ocular
problem
ex
vivo
peptid
stimul
elicit
cytokin
product
protein
target
human
ebovspecif
tcell
character
respons
viral
nucleoprotein
np
abund
conserv
protein
among
filovirus
present
major
patient
induct
reaction
peptid
deriv
ebola
glycoprotein
gp
viral
protein
variabl
among
individu
lower
magnitud
importantli
vaccin
candid
ebov
rvsvzebov
incorpor
ebov
gp
vector
possibl
impair
induct
protect
tcell
respons
inde
strong
protect
tcell
respons
induc
immun
ebov
npexpress
vector
npdna
vaccin
mice
vaccin
nonhuman
primat
ebovlik
particl
induc
strong
npspecif
tcell
respons
least
partial
respons
diseas
protect
addit
adopt
transfer
npspecif
tcell
protect
ebovchalleng
mice
togeth
data
highlight
import
np
effect
tcell
respons
ebov
vaccin
furthermor
specul
success
npcontain
vector
reli
fact
np
contribut
structurallyst
particl
vaccin
known
effici
boost
immun
good
exampl
recent
success
ebov
vaccin
express
ebov
gp
form
viruslik
particl
vivo
success
protect
nhp
lethal
challeng
although
tcell
appar
dispens
acut
ebov
infect
may
play
import
role
stimul
bcell
respons
antiebov
antibodi
product
import
correl
ebov
protect
vaccin
studi
instanc
frequenc
circul
tcell
blood
counterpart
follicular
tcell
correl
antibodi
titer
induc
rvsvzebov
vaccin
candid
human
addit
follicular
tcell
subset
expand
filoviruseslik
particl
vaccin
mice
popul
support
bcell
antibodi
product
via
interact
thu
stimul
follicular
tcell
also
target
ebov
vaccin
candid
although
import
gap
remain
understand
tcell
respons
hantavirus
avail
data
indic
associ
diseas
protect
first
report
indic
role
tcell
resist
mice
htnv
infect
htnvchalleng
mice
protect
adopt
transfer
complet
immun
spleen
cell
tcelldeplet
cell
htnvspecif
tcell
induc
patient
hfr
frequenc
higher
patient
mildmoder
diseas
compar
severecrit
hfr
patient
clinic
remiss
sever
hfr
also
associ
sustain
b
tcell
respons
even
absenc
detect
neutral
antibodi
contrast
low
tcell
respons
also
associ
sever
hfr
among
total
tcell
subset
respons
major
respons
htnv
peptid
inde
htnvspecif
tcell
requir
effici
viral
clearanc
mice
via
product
cytotox
low
frequenc
lead
persist
infect
seen
hantaviru
reservoir
deer
mice
addit
hantaviru
nucleocapsid
protein
inhibit
activ
granzym
b
caspas
apoptosi
infect
endotheli
cell
consist
immun
evas
mechan
virus
explain
persist
rodent
reservoir
tcell
also
import
htnv
infect
control
favor
clinic
outcom
polyfunct
cytokin
respons
cytotox
mechan
note
comparison
hantavirus
crimeancongo
hemorrhag
fever
viru
cchfv
rift
valley
fever
viru
rvfv
arthropodborn
diseas
rout
transmiss
could
influenc
tcell
respons
howev
avail
data
indic
tcell
undergo
similar
activ
profil
cchfvchalleng
human
mice
rvfvchalleng
mice
tcell
import
protect
rvfv
challeng
mice
wherea
human
be
infect
induc
longliv
memori
tcell
final
remain
determin
differ
tcell
respons
old
new
world
hantavirus
may
account
differ
clinic
syndrom
found
infect
similar
vhf
massiv
increas
frequenc
circul
hladr
tcell
observ
acut
human
hantavirus
infect
follow
contract
phase
coincid
viral
clearanc
cell
exhibit
low
express
high
express
perforin
granzym
b
consist
effector
memori
profil
invers
ratio
also
observ
hfr
interestingli
human
tcell
display
differenti
pattern
express
acut
hantavirus
infect
thu
tcell
high
express
inhibitori
receptor
wherea
tcell
express
may
account
effici
tcell
respons
infect
also
tendenc
immunopatholog
discuss
sever
report
evalu
human
tcell
epitop
hantavirus
patient
hp
caus
sin
nombr
viru
snv
tcell
recogn
epitop
viral
nucleocapsid
protein
restrict
wherea
tcell
recogn
epitop
viral
nucleocapsid
protein
restrict
htnv
nucleocapsid
protein
epitop
restrict
also
recogn
tcell
patient
hfr
individu
laboratoryacquir
htnv
infect
recognit
nucleocapsid
protein
expect
sever
hantavirus
share
conserv
sequenc
protein
howev
clinic
relev
virus
puumala
viru
exhibit
nucleocapsid
protein
sequenc
variant
differ
immunodomin
epitop
may
evad
effici
tcell
respons
limit
crossprotect
among
hantavirus
addit
human
tcell
also
recogn
epitop
hantavirus
glycoprotein
inde
glycoprotein
contain
amino
acid
tail
select
direct
proteasom
degrad
would
increas
present
hla
class
pathway
consist
immun
syrian
hamster
adenovir
vector
express
and
viru
nucleocapsid
glycoprotein
protect
viral
challeng
import
contribut
cytotox
tcell
similar
protect
observ
bank
vole
immun
puumala
viru
nucleocapsid
protein
strikingli
immun
bank
vole
nucleocapsid
protein
differ
hantaviru
strain
elicit
crossprotect
tcell
respons
puumala
viru
collect
studi
underlin
import
tcell
immun
protect
hantaviru
infect
support
relev
nucleocapsid
protein
gener
crossprotect
use
novel
vaccin
candid
importantli
although
tcell
associ
hantavirus
diseas
protect
role
immunopatholog
also
suggest
htnvinduc
meningoenceph
mice
associ
tcell
mediat
immun
hla
class
allel
particularli
also
associ
sever
puumala
viru
infect
similarli
patient
fulmin
hp
exhibit
higher
frequenc
snvspecif
tcell
compar
patient
moder
diseas
excess
product
like
induc
damag
pulmonari
endotheli
cell
contribut
observ
capillari
leakag
hp
inde
fatal
hp
character
increas
frequenc
cytokineproduc
cell
lung
unchang
frequenc
regulatori
tcell
lower
express
inhibitori
receptor
tcell
decreas
level
regulatori
cytokin
could
also
contribut
exacerb
tcell
respons
hantaviru
infect
summari
magnitud
qualiti
tcell
respons
well
host
characterist
determin
final
outcom
hantaviru
infect
studi
defin
immun
featur
requir
improv
diseas
manag
prognosi
well
contribut
vaccin
develop
yellow
fever
prototyp
diseas
studi
tcell
respons
elicit
viral
infect
vaccin
figur
vaccin
live
attenu
vaccin
contain
structur
nonstructur
ns
protein
yfv
one
safe
effect
vaccin
current
avail
induc
seroconvers
memori
tcell
respons
individu
studi
neutral
antibodi
protect
level
longliv
memori
tcell
year
interact
replic
dendrit
cell
stimul
express
mhc
costimulatori
molecul
product
inflammatori
cytokin
present
domin
epitop
togeth
promot
effici
tcell
prime
thu
tcell
respons
gener
immun
complement
neutral
antibodi
respons
critic
protect
evid
protect
effect
tcell
respons
yfv
includ
deplet
tcell
bcell
defici
mice
abolish
vaccineinduc
control
intracerebr
viral
challeng
ii
polyfunct
tcell
respons
immun
complement
neutral
antibodi
protect
virul
yfv
challeng
mice
iii
restrict
viscerotrop
neurotrop
dissemin
mechan
vivo
attenu
vaccin
iv
cytokineproduc
human
tcell
express
molecul
import
stimul
bcell
respons
associ
level
neutral
antibodi
immun
vaccineinduc
protect
mice
vaccin
increas
level
solubl
marker
immun
activ
neopterin
accordingli
increas
frequenc
human
hladr
tcell
observ
seven
day
postvaccin
coincid
viru
clearanc
peak
two
week
return
prevaccin
level
one
month
figur
peak
tcell
respons
appear
earlier
tcell
yfvspecif
tcell
follow
similar
kinet
remain
detect
month
postvaccin
acut
phase
cell
exhibit
effector
profil
high
express
chemokin
receptor
allow
migrat
inflam
tissu
granzym
b
low
level
effector
phase
follow
acquisit
memori
profil
invers
express
mention
molecul
high
express
tbet
transcript
factor
character
effector
cell
also
observ
earli
vaccin
shift
predomin
eomesodermin
express
transcript
factor
character
memori
cell
three
month
postimmun
interestingli
low
undetect
bystand
activ
tcell
observ
vaccin
indic
increas
effector
cell
vaccinespecif
remark
induc
broad
human
tcell
respons
detect
cytokin
product
stimul
epitop
deriv
protein
find
consist
divers
tcell
receptor
repertoir
observ
yfvspecif
tcell
postvaccin
nonetheless
major
antigenspecif
popul
direct
epitop
e
protein
magnitud
tcell
respons
also
associ
promiscu
bind
epitop
hla
class
ii
molecul
remark
tcell
respons
elicit
polyfunct
wherea
differ
effector
tcell
profil
typei
ii
effector
mechan
observ
depend
pathogenrecognit
receptor
activ
antigenpres
cell
along
robust
effector
tcell
respons
earli
vaccin
longliv
memori
tcell
also
induc
figur
yfv
tetram
cell
detect
year
singl
vaccin
robust
memori
tcell
respons
recal
ex
vivo
stimul
recent
studi
describ
turnov
human
memori
yfvspecif
tcell
induc
vaccin
vaccin
individu
receiv
deuter
water
differ
time
point
evalu
incorpor
dna
measur
cell
replic
low
prolifer
memori
cell
observ
effector
phase
sequenti
expans
contract
number
effector
cell
occur
divid
day
surviv
year
immun
longliv
memori
cell
retain
epigenet
memori
effector
cell
pois
exert
effector
function
restimul
interestingli
neither
magnitud
qualiti
yfvspecif
tcell
respons
influenc
vaccin
booster
figur
find
explain
antibodi
neutral
rapid
clearanc
viral
load
secondari
immun
prevent
effici
stimul
immun
system
inde
magnitud
human
tcell
respons
primari
immun
highli
determin
initi
viral
load
find
indic
tcellmedi
immun
induc
live
attenu
vaccin
depend
antigen
level
reach
immun
mechan
explain
highli
protect
immun
respons
elicit
singl
immun
dengu
fever
typic
diseas
immun
mechan
determin
pathogenesi
clinic
sever
presenc
four
antigen
relat
serotyp
addit
closelyrel
flavivirus
eg
zikv
circul
endem
area
crossreact
nonneutr
immun
respons
explain
higher
frequenc
sever
diseas
secondari
infect
differ
denv
serotyp
addit
sever
manifest
occur
follow
viral
clearanc
impli
immun
respons
elicit
viru
major
caus
patholog
case
tcell
respons
denv
excess
product
proinflammatori
cytokin
known
cytokin
storm
respons
endotheli
damag
vascular
leakag
shock
accordingli
hlaa
b
allel
time
tcell
respons
magnitud
activ
effector
molecul
associ
develop
sever
dengu
inde
human
tcell
major
target
multipl
stimul
factor
chemoattract
deriv
monocyt
dendrit
cell
bcell
induc
massiv
activ
denv
infect
thu
serotyp
crossreact
denvspecif
tcell
gener
primari
infect
exacerb
cytokin
lytic
respons
induc
organ
damag
competit
tcell
avid
current
infect
serotyp
enhanc
denv
infect
target
cell
mechan
patholog
role
tcell
secondari
denv
infect
nonetheless
host
factor
determin
dengu
fever
patholog
clinic
outcom
remain
determin
similar
vhf
denv
infect
antigenpres
cell
affect
tcell
prime
capac
could
relat
delay
appear
denvspecif
tcell
turn
associ
develop
sever
manifest
denv
infect
also
induc
tcell
apoptosi
affect
ex
vivo
respons
polyclon
stimuli
could
confer
suscept
coinfect
protect
role
tcell
respons
also
demonstr
denv
flaviviru
infect
natur
vaccin
challeng
strong
tcell
respons
induc
denv
natur
infect
exhibit
effector
memori
phenotyp
product
cytotox
potenti
addit
denvspecif
tcell
home
skin
major
site
denv
replic
express
cutan
lymphocyteassoci
antigen
suggest
immun
surveil
function
memori
tcell
vivo
serotypespecif
crossreact
tcell
contribut
viral
clearanc
denv
challeng
transgen
mice
high
frequenc
memori
tcell
specif
conserv
epitop
denv
serotyp
associ
protect
secondari
clinic
infect
endem
area
wherea
individu
express
particular
protect
hla
class
allel
exhibit
strong
tcell
respons
protect
reinfect
moreov
individu
earli
denvspecif
tcell
respons
exhibit
lower
viremia
develop
milder
clinic
diseas
cytotox
tcell
also
play
protect
role
denv
infect
immun
tcell
epitop
prior
infect
contribut
viral
clearanc
subsequ
viral
challeng
mice
hladr
allel
associ
diseas
resist
well
broad
epitop
reactiv
human
tcell
support
protect
role
tcell
denv
infect
thu
evid
tcellmedi
protect
denv
infect
tcell
propos
immun
correl
protect
diseas
importantli
antigen
relat
sever
flavivirus
allow
tcellmedi
crossprotect
critic
broadli
protect
flaviviru
vaccin
inde
denvspecif
tcell
denvimmun
serum
confer
crossprotect
subsequ
zika
viru
zikv
infect
mice
immun
crossreact
zikvdenv
epitop
protect
subsequ
zikv
challeng
tcelldepend
mechan
mice
sequenti
flaviviru
immun
also
confer
tcellmedi
crossprotect
subsequ
denv
infect
mice
wherea
flaviviru
crossreact
human
memori
tcell
reactiv
heterolog
viru
exposur
exhibit
respons
prior
denv
exposur
natur
vaccin
also
influenc
time
magnitud
human
tcell
respons
subsequ
zikv
infect
point
protect
effect
viral
exposur
improv
tcell
respons
least
human
tcell
epitop
identifi
flavivirus
major
denv
although
human
tcell
epitop
found
denv
structur
protein
domin
respons
direct
nonstructur
protein
ns
particularli
interestingli
denv
epitop
differenti
target
serotyp
elicit
nsspecif
tcell
respons
induc
respons
structur
c
e
protein
addit
import
sequenc
homolog
zikv
flavivirus
highlight
valu
protein
induct
human
tcell
respons
sever
vaccin
candid
denv
test
advanc
tetraval
chimer
vaccin
base
live
attenu
vaccin
vaccin
incorpor
prem
e
protein
denv
serotyp
backbon
nonstructur
protein
yfv
similar
tetraval
chimer
vaccin
also
demonstr
safeti
immunogen
preclin
clinic
studi
remark
efficaci
result
phase
studi
entir
explain
magnitud
neutral
antibodi
cellular
immun
could
complementari
role
confer
protect
certainli
tcell
respons
particularli
cell
elicit
chimer
vaccin
immun
mice
tcell
respons
prem
e
protein
observ
confer
protect
subsequ
intracerebr
challeng
wherea
tcell
deplet
abrog
protect
effect
howev
human
antigenspecif
tcell
induc
tetraval
vaccin
direct
yfv
denv
protein
although
remain
confirm
vaccineinduc
tcell
respons
could
exert
crossprotect
role
denv
infect
could
also
promot
suboptim
respons
immunopatholog
secondari
exposur
discuss
could
explain
higher
incid
hospit
dengu
fever
children
younger
year
age
vaccin
tetraval
chimer
vaccin
importantli
accord
immunodomin
protein
human
vaccin
vaccin
live
attenu
vaccin
contain
denv
structur
nonstructur
protein
elicit
strong
polyfunct
respons
compar
induc
natur
infect
data
support
inclus
denv
ns
protein
vaccin
candid
order
improv
tcell
respons
possibl
protect
confer
vaccin
remark
earli
massiv
activ
differenti
human
effector
tcell
observ
acut
denv
infect
hladr
cell
constitut
total
circul
tcell
individu
howev
small
fraction
activ
tcell
denvspecif
observ
relat
massiv
apoptosi
highavid
antigenspecif
tcell
acut
infect
addit
denvspecif
tcell
lowaffin
serotyp
crossreact
expans
would
impair
overal
tcell
respons
viral
clearanc
certainli
activ
high
avid
antigenspecif
tcell
may
result
subsequ
optim
signaltransduct
machineri
preferenti
product
compar
low
avid
antigenspecif
cell
would
confer
longlast
protect
function
tcell
infect
accordingli
children
maintain
higher
frequenc
denvspecif
tcell
get
reinfect
denv
experi
subclin
infect
compar
children
develop
symptomat
secondari
infect
lower
frequenc
antigenspecif
subset
gene
relat
antigen
present
tcell
costimul
tcell
receptor
signal
signal
also
overexpress
patient
mild
diseas
compar
sever
dengu
contrast
serotyp
crossreact
denvspecif
tcell
lower
degranul
higher
product
proinflammatori
cytokin
may
limit
elimin
infect
cell
drive
immunopatholog
higher
diseas
sever
secondari
infect
accordingli
preexist
proinflammatori
pattern
tcell
associ
subsequ
develop
sever
secondari
denv
infect
wherea
express
denvspecif
tcell
correl
protect
associ
antivir
mechan
suggest
regul
excess
immun
respons
critic
diseas
resist
thu
longlast
protect
role
tcell
denv
associ
effici
tcell
prime
antigenpres
cell
express
particular
hla
molecul
modul
bystand
activ
mainten
high
affin
antigenspecif
memori
tcell
howev
death
highaffin
denvspecif
tcell
induc
predomin
lowaffin
bystanderactiv
tcell
serotyp
crossreact
tcell
case
denv
secondari
infect
produc
proinflammatori
cytokin
low
product
induc
endotheli
dysfunct
vascular
leakag
organ
damag
figur
model
may
appli
vhf
massiv
bystand
activ
apoptosi
antigenspecif
tcell
observ
interplay
viru
host
import
determin
pathogenesi
clinic
outcom
vhf
tcell
critic
control
human
vhf
magnitud
respons
relat
diseas
sever
surviv
protect
induct
effici
tcell
respons
also
correl
vaccineinduc
protect
thu
research
effort
focu
studi
mechan
protect
defect
immun
respons
fatal
outcom
immunodomin
preferenti
crossprotect
epitop
relev
subset
human
tcell
respons
vhf
activ
marker
hladr
import
predictor
kinet
tcell
respons
acut
infect
valuabl
vaccin
studi
interact
bcell
tcell
gener
protect
antibodi
respons
also
import
improv
current
vaccin
candid
